Related Experiment Video
Updated: Aug 19, 2026

Using the Threat Probability Task to Assess Anxiety and Fear During Uncertain and Certain Threat
Published on: September 12, 2014
New advances in the management of anxiety disorders
1Anxiety Disorders Program, Massachusetts General Hospital, Boston, MA, USA.
Abstract:
Anxiety disorders are highly prevalent and associated with significant symptomatic distress, increased morbidity, and increased mortality. Although efficacious pharmacologic and psychosocial therapies for the anxiety disorders are available, many patients who improve with treatment remain at least somewhat symptomatic. This article reviews the epidemiology, phenomenology, and associated complications of panic disorder, social anxiety disorder, posttraumatic stress disorder, and generalized anxiety disorder. Recent guidelines developed for application in the assessment of outcome of the anxiety disorders are discussed, and illustrative data from a number of treatment trials integrating remission data in assessment of outcome are examined.
Related Concept Videos
Anxiety: Overview
Individuals with anxiety often experience a range of physical and emotional symptoms, including sweating, trembling, tachycardia, and disturbances in sleep patterns. These symptoms vary in intensity and frequency but are generally disruptive and distressing.
Anxiolytic Drugs: Overview
Primary Types of Anxiolytic Drugs
1. Benzodiazepines:
Benzodiazepines bind to the GABA-A receptor in the brain, enhancing GABA's interaction. This action reduces neurotransmission, effectively blocking anxiety-associated limbic circuitry.
Anxiolytic Drugs: Benzodiazepines and Buspirone
Panic Disorder
Behavior Therapy
Exposure therapy is a cornerstone of behavioral treatment for anxiety disorders. It involves systematic exposure to feared stimuli, either in real...
Drug Therapy
Antianxiety Medications

